Related Experiment Videos
NF-kappaB modulates lipopolysaccharide-induced microglial nerve growth factor expression
K Heese1, B L Fiebich, J Bauer
1Department of Physiology, University of Basel, Vesalianum, Switzerland.
Glia
|March 28, 1998
Summary
Activated microglia release nerve growth factor (NGF) via the NF-kappaB pathway. This process is crucial for communication between the immune and nervous systems during central nervous system inflammation.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia, the brain's immune cells, play dual roles in neuroinflammation, exhibiting both harmful and helpful effects.
- While microglial cytotoxicity is well-studied, the signaling pathways governing their neurotrophic factor production remain largely unknown.
Purpose of the Study:
- To investigate the signaling mechanisms underlying nerve growth factor (NGF) expression in activated microglia.
- To determine the role of the transcription factor NF-kappaB in inflammatory mediator-induced NGF production by microglia.
Main Methods:
- Utilized primary rat microglial cell cultures exposed to lipopolysaccharide (LPS), a potent inflammatory agent.
- Assessed NGF mRNA and protein levels following LPS stimulation.
- Employed the NF-kappaB inhibitor pyrrolidine dithiocarbamate (PDTC) to probe the involvement of this transcription factor.
Main Results:
- Lipopolysaccharide (LPS) treatment dose-dependently increased both NGF mRNA and protein levels in microglia.
- NGF expression was rapidly induced by LPS within 2-4 hours, with enhanced protein release observed at 24 hours.
- Inhibition of NF-kappaB with PDTC completely blocked LPS-induced NGF synthesis, confirming NF-kappaB's critical role.
Conclusions:
- NF-kappaB signaling is essential for inflammatory mediator-induced NGF expression in activated microglia.
- This NF-kappaB-dependent NGF production by microglia contributes to neuro-immune system communication during central nervous system inflammation.